Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ADA 2020
Pharma
Steglatro rings up CV safety win but still lags SGLT2 peers
Merck and Pfizer’s Steglatro, late the SGLT2 party, has been working to catch up to its in-class rivals, which already bear heart-helping approvals.
Carly Helfand
Jun 16, 2020 1:15pm
AstraZeneca's Farxiga cuts risk of fast kidney function decline
Jun 15, 2020 3:45pm
AZ's Farxiga cuts risk of diabetes in heart failure patients
Jun 15, 2020 9:15am
Novo's long-lasting insulin candidate matches Lantus in phase 2
Jun 14, 2020 6:55pm
Lilly's Trulicity tops Ozempic at keeping patients compliant
Jun 14, 2020 2:54pm
Sanofi boosts Soliqua with real-world data favoring dual therapy
Jun 13, 2020 11:00am
